Clinical trial

Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

NCT03390712

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2018-01-02

PhaseN/A

Study timeline

Study start (estimated)2018-01-02Date precision: day

Registry last updated2018-01-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophrenia Spectrum and Other Psychotic Disordersunresolved

Interventions

Paliperidone PalmitateDRUG · verified · RxNorm: paliperidone palmitate

Risperidal ConstaDRUG

AntipsychoticDRUG

Sponsors & collaborators

Réseau de Santé Vitalité Health Networklead sponsor

Janssen Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03390712 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.